In cat, although Michishita et al. (2016) demonstrated that bevacizumab suppressed tumor growth in a xenograft model, suggesting its potential therapeutic effect for FMC [29], the role of VEGF-A in angiogenesis and its biological effects in feline mammary carcinoma is still poorly documented. The gene discussed is VEGFA; the disease is neoplasm.